Brett Chevalier is a Chief Scientific Officer at Anterra Capital, whose known portfolio counts 8 companies.
Is Brett Chevalier a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- ClimateFoodHealthcare
- Focus
- AgriTechAlt ProteinAnimal HealthBiotechFermentationFoodTech
Contacts
Affiliated funds' portfolios
Chief Scientific Officer at Anterra Capital, whose known portfolio counts 8 companies
- BiomEdit
- Anchr
- Animol Discovery
- Berkeley Yeast
- AgrigateOne
- Dalma
- Bonito Biosciences
- Edge Animal Health
Investor Profile
The listing covers sectors Climate, Food and Healthcare, and focus areas AgriTech, Alt Protein, Animal Health and Biotech. Startups operating in these areas may find Brett Chevalier relevant.
Stage-wise, the deals at Anterra Capital cluster around Growth, Pre-Seed and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Brett Chevalier is worth approaching.
Colleagues at Anterra Capital
Adam Anders
Founder & Managing Partner
Amsterdam, Netherlands
Brett Wong
Partner
Brookline, United States
Maarten Goossens
Founding Partner
Amsterdam, Netherlands
Sanjay Birjmohan
Investment Associate
Netherlands
Axel Wehr
Venture Partner
United Kingdom
Philip Austin
Founding Partner
Boston, United States
Kanupriya Rungta
Investor
New Delhi, India
Frequently asked questions
Who is Brett Chevalier?
Brett Chevalier is a venture capital investor based in Cambridge, Massachusetts, United States, listed as Chief Scientific Officer at Anterra Capital. The known portfolio of that firm counts 8 companies. That portfolio belongs to the firm, not to Brett Chevalier personally.
What does Brett Chevalier invest in?
Listed sectors include Climate, Food and Healthcare; listed focus areas include AgriTech, Alt Protein, Animal Health and Biotech. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Brett Chevalier invest at?
Anterra Capital appears in Growth, Pre-Seed and Seed rounds across its known deals, and Brett Chevalier is listed there as Chief Scientific Officer. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Brett Chevalier listed at?
Brett Chevalier is listed as Chief Scientific Officer at Anterra Capital. 7 other people in the database share a firm with Brett Chevalier.
How do I contact Brett Chevalier?
An email address, a phone number and a LinkedIn page are on file for Brett Chevalier. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal